Epiroc AB (publ) (OTCMKTS:EPOKY – Get Free Report) saw a large decrease in short interest in the month of November. As of November 15th, there was short interest totalling 1,900 shares, a decrease of 96.8% from the October 31st total of 59,900 shares. Based on an average daily volume of 285,300 shares, the days-to-cover ratio is presently 0.0 days.
Epiroc AB (publ) Price Performance
OTCMKTS EPOKY traded up $0.22 during trading hours on Wednesday, reaching $17.88. The company’s stock had a trading volume of 172,373 shares, compared to its average volume of 190,256. The firm has a market capitalization of $21.58 billion, a price-to-earnings ratio of 25.97, a P/E/G ratio of 12.80 and a beta of 1.58. Epiroc AB has a 1-year low of $17.23 and a 1-year high of $21.74. The company has a debt-to-equity ratio of 0.46, a current ratio of 2.06 and a quick ratio of 1.12. The company’s 50-day moving average is $19.63 and its two-hundred day moving average is $19.54.
Epiroc AB (publ) (OTCMKTS:EPOKY – Get Free Report) last released its earnings results on Friday, October 25th. The company reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.16 by $0.02. The business had revenue of $1.51 billion for the quarter. Epiroc AB (publ) had a return on equity of 22.16% and a net margin of 13.94%. On average, equities analysts predict that Epiroc AB will post 0.72 EPS for the current year.
Epiroc AB (publ) Increases Dividend
About Epiroc AB (publ)
Epiroc AB (publ), together with its subsidiaries, develops and produces equipment for use in surface and underground applications in North America, Europe, South America, Europe, Africa, the Middle East, Asia, and Australia. It operates in two segments, Equipment & Service, and Tools & Attachments.
Featured Articles
- Five stocks we like better than Epiroc AB (publ)
- Basic Materials Stocks Investing
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- ESG Stocks, What Investors Should Know
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What is a Death Cross in Stocks?
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Epiroc AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Epiroc AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.